Who are we

Saga is a net of consultants with vast hands-on experience in biotechnology industry. Saga members have worked in different roles in the biopharma industry. This knowledge is key factor.



Industry Trend 2020-2023

The challenges of the new post-COVID era are still not fully understood. Never before has a pandemic been addressed to the extent of producing multiple vaccines and therapeutic treatments in less than two years. The responses from both governments and the private sector have significantly surpassed the capabilities of 2019.

Since the onset of COVID in late 2019, the most notable limitations have been in materials resources and production capabilities. These challenges are being addressed in the current plans of leading companies in supplies (such as Thermo Fisher, Avantor, Cytiva, Pall, Repligen, Millipore, Sartorius, etc.) and operations (including existing and new CDMOs, CMOs, and traditional manufacturers).

The solutions provided by these significant pharmaceutical companies create an ideal scenario for the origin of SAGA: "With so many new facilities and a low chance of failure, the future of any company needs to be led by capable and knowledgeable people." This encapsulates the ultimate meaning of SAGA: to deliver success.

Human Resources became the third factor (besides supplies and capabilities) in the biotech industry, and today, it is treated as a currency and a success indicator. Besides the scarcity of personnel, HR quality and knowledge are often questionable. Companies are always in a race to obtain the new HR currency, and employee work experiences are averaging less than ever at the more prominent US biotech hubs.



Industry Trend 2023-2025+

The Biotech scenario has changed, COVID anxiety has passed, and the world's attention has drifted to war conflicts and new phenomena. There is an evident contraction in the market, represented by multiple layoffs, project holds, and cancellations.

Regardless, the upcoming years will be marked by the excitement of novel Gene and Cell Therapy products and the intention of making the world a better place for patients. The COVID lesson on maintaining facility readiness and the new expertise and expectations of leading regulatory groups will keep the new smaller market highly competitive.



SAGA’s Vision in a Challenging Era

As the biotech industry shifts from a phase of global urgency to one of measured innovation and consolidation, SAGA’s role becomes ever more crucial. By providing the right expertise at the right time, SAGA empowers companies to navigate the present challenges and lay a foundation for a resilient and prosperous future. Its commitment to fostering excellence, even in a contracted market, underscores its impact as a driving force in the biotech sector’s evolution. By deploying personnel with deep expertise precisely when and where they are needed, SAGA enables biotech companies to maintain momentum on essential projects without committing to long-term overhead costs.



SAGA’s Core Values

Flexibility

  • We embody flexibility in both mind and movement, adapting swiftly to the evolving needs of our clients and the dynamic nature of the biotech industry. Our open-minded approach enables us to embrace new ideas, technologies, and methodologies, while our operational agility ensures we can pivot seamlessly to meet changing project demands. Whether addressing complex challenges, scaling resources, or tailoring solutions, we prioritize responsiveness and adaptability without compromising quality.

Quality

  • As a biotech contractor and consultant, our unwavering commitment to quality underpins everything we do. We strive to deliver exceptional results by adhering to rigorous industry standards, maintaining meticulous attention to detail, and fostering a culture of continuous improvement. From ensuring compliance with regulatory requirements to implementing innovative solutions, we prioritize precision, reliability, and excellence in every aspect of our work.

Knowledge

  • Our technological and industry knowledge stems from the meaningful and diverse experiences of our team members, gained through hands-on roles in the operation floor, development labs, training classes, supply chain, validation, and quality functions. This breadth of expertise equips us with a comprehensive understanding of the biotech industry's interconnected processes and challenges. By drawing on real-world experience and a deep commitment to staying at the forefront of industry and technological advancements, we provide innovative, practical, and impactful solutions. This knowledge enables us to support our clients in achieving excellence at every stage of their journey.

Dedication

  • Our dedication is driven by an unwavering focus on our clients, who are the driving force behind our work. Their success is not just a goal—it is the ultimate objective of our group. We are committed to understanding their needs, aligning with their vision, and delivering solutions that exceed expectations. By fostering strong partnerships and going above and beyond in every endeavor, we ensure that our efforts are fully directed toward empowering our clients to achieve their goals and make lasting impacts in the biotech industry.

Passion

  • At SAGA, our passion defines us. We are committed to adopting and caring for your challenges as if they were our own, engaging with unwavering enthusiasm and dedication. From routine bioreactor surveillance to groundbreaking experimentation in the lab, and across roles in the plant, audit preparation, management, training, and beyond, every member of our team approaches their work with a deep sense of purpose. Our passion ensures that no task is too routine or too complex—we embrace every opportunity to contribute with creativity, focus, and a relentless drive to deliver impactful solutions.